Skip to content

Clinical study on prevention and treatment of atherosclerosis in patients with metabolic syndrome with Xiaochaihu decoction

Clinical study on prevention and treatment of atherosclerosis in patients with metabolic syndrome with Xiaochaihu decoction

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032470
Enrollment
Unknown
Registered
2020-04-29
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic syndrome ,atherosclerosis

Interventions

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who meet the above diagnostic criteria of Western medicine, i.e. metabolic syndrome. 2. The age of the patients who are in accordance with the syndrome is between 18 and 70 years old. 3. Patients with informed consent, signing informed consent and voluntary test.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women. 2. Type 1 diabetes, gestational diabetes and other types of diabetes, secondary hypertension and / or hyperlipidemia. 3. Patients with serious heart, liver, kidney and other complications or with other serious primary diseases and psychosis.

Design outcomes

Primary

MeasureTime frame
carotid artery ultrasound;

Secondary

MeasureTime frame
Pulse wave velocity and ankle-brachial index were detected;

Countries

China

Contacts

Public ContactWang Bing

Shanghai sixth people's hospital

ebingliver@163.com+86 18930177667

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026